Home > > > > Report Detail

Viral Vector and Plasmid DNA: Technologies and Global Markets

Publisher Name :
Date: 18-Sep-2019
No. of pages: 133

Report Scope:

The report provides a comprehensive summary of the viral vector and plasmid DNA technologies market, along with detailed profiles of key market players that includes revenue product portfolio and recent activities. The report analyzes trends and dynamics, including drivers, limitations and challenges and opportunities. The report discusses strategies adopted by emerging market players with recommendations for the new market entrants. This research study discusses historical, current, and potential market size. The report will enable market players and new entrants to make informed decisions about the production and exports of the goods and services to the original equipment manufacturer. Organizations, distributors and exporters should find the information about market development and trends useful.

The study segments the market on the basis of product type, applications and end-use. Geographical market analysis is provided for all the major segments. The report offers country level analysis of markets to provide better understanding of the major segments.

Report Includes:


  • 44 data tables and 14 additional tables

  • An in-depth assessment of the global viral vector and plasmid DNA technologies market within the life sciences sectors

  • Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024

  • The latest information on key technical advances in different viral vector and plasmid DNA technologies, and the extent of adoption by commercial customers and regulatory authorities

  • A proprietary analysis of the market including an easy-to-understand graphical representation of facts, innovations in pharmaceutical and biotechnology companies, and R&D activities in viral vector-based treatments and Plasmid DNA vaccines

  • Key strategies adopted by major players in the market and the impact of new technological developments in developed and emerging markets

  • Assessment of the suppliers’ landscape on the basis of companies best positioned to meet this ever evolving demand

  • Comprehensive company profiles of market leading players, including Aldevron LLC, Merck KGaA, Lonza Group Ltd., GenScript Biotech Corp., Pfizer Inc., and Thermo Fisher Scientific, Inc."


Summary

Viral vectors are viruses developed through cultured DNA recombination techniques. This modification makes the viruses ideal for delivering genetic material into target cells or tissues for therapeutic purposes. Types of viral vectors include adenoviruses, retroviruses, poxviruses, adeno-associated viruses (AAV), and herpes simplex viruses (HSVs). Delivery of foreign DNA using viral vectors has flaws, particularly when attempts are made to apply the technology to gene therapy. However, as researchers learn more about viral vectors and their impact on human immune response, advancements in safe and effective viral-based treatments continue. Meanwhile, the refinement of viral-mediated gene delivery

protocols proceeds, providing a convenient, flexible, and reproducible system for in vitro transfection studies. Plasmid DNA vaccines offer speed, simplicity, and breadth of immune response by overcoming the issues regarding effectiveness and safety of therapy during treatment. Innovative plasmid DNA vaccines can be useful for the immunization of humans against infectious diseases and cancers.

The global viral vector and plasmid DNA technologies market is estimated to grow significantly, reaching a compound annual growth rate (CAGR) of REDACTED during the forecast period, 2019-2024. The global viral vector and plasmid DNA technologies market was valued at REDACTED in 2018 and is projected to exceed REDACTED by 2024. The market’s projected growth stems from factors such as the rising prevalence of various diseases such as cancer, infectious diseases, and other genetic disorders, the growing trend toward gene therapy owing to their promising clinical results, and increasing partnerships and collaborations between companies and research institutes in gene therapy.

The rising incidence and prevalence rate of cancer is considered a key factor in the growth of the global viral vector and plasmid DNA technologies market. According to the WHO (World Health Organization), cancer is the second-leading cause of mortality in the world, responsible for 9.6 million deaths and accounting for 18.1 million new cases in 2018. Consequently, there is significant demand for cancer therapeutics based on innovative technologies such as viral vectors and plasmid DNA. Viral vectors are being researched for applications in cancer therapies and to support the delivery of genetic information to a tumor, which will permit the development of therapeutic proteins. The process typically involves introducing DNA into a cell (transfection), which encodes for a protein and other important genetic elements needed for the introduction of the gene of interest expression that facilitates successful production of protein. Some approved gene therapies, like Kymriah for acute lymphoblastic leukemia (ALL) and large B cell lymphoma, have induced market players to research and develop of gene therapy for cancer treatment. However, regulatory challenges, vector characterization and QC testing, and manufacturing challenges have restrained growth in the global viral vector and plasmid DNA technologies market.

The global viral vector and plasmid DNA technologies market was segmented based on product, application and end-user. Based on product, the global viral vector and plasmid DNA technologies market further is analyzed into plasmid DNA and viral vectors. Among products, the viral vector segment held the largest share in the viral vector and plasmid DNA technologies market with a value of REDACTED in 2018. The market is projected to reach REDACTED by 2024, growing at a CAGR of REDACTED during the forecast period. The viral vector is the most operative resource of gene transfer to modify specific cell type or tissue and can be manipulated to express therapeutic genes. Various types of viruses include adenoviruses, retroviruses (γ-retroviruses and lentiviruses), poxviruses, AAV, baculoviruses and HSV. These viruses are under investigation as applications to deliver genes to cells for either transient or permanent transgene expression. The rising applications of these viruses should boost growth of the viral vector in gene therapy.

Viral Vector and Plasmid DNA: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Gene Therapy
Plasmid Production
Description of Market Trends
Market Dynamics
Chapter 4 Market Breakdown by Product Type
Plasmid DNA
Viral Vector
Chapter 5 Market Breakdown by End User
Research Institutes
Pharmaceutical and Biopharmaceutical Companies
Chapter 6 Market Breakdown by Application
Cancer
Infectious Diseases
CVD
Other Applications
Chapter 7 Market Breakdown by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Middle East and Africa (MEA)
Latin America
Chapter 8 Patent Review/New Developments
New Products and Technologies
Patent Analysis
Chapter 9 Analysis of Market Opportunities
Key Suppliers and Manufacturers: Positioning and Strategy
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza Group Ltd.
GenScript Biotech Corp.
Pfizer Inc.
R&D Programs
Pipeline Analysis
Discovery
Chapter 10 Company Profiles
ABEONA THERAPEUTICS INC.
AKRON BIOTECH
ALDEVRON, LLC
AMARNA THERAPEUTICS B.V.
APPLIED BIOLOGICAL MATERIALS INC.
AUDENTES THERAPEUTICS INC.
BATAVIA BIOSCIENCES B.V.
BAYER AG
BIOMARIN PHARMACEUTICAL INC.
BIONTECH IMFS GMBH
BLUEBIRD BIO INC.
CELLECTA INC.
COBRA BIOLOGICS LTD.
CRISPR THERAPEUTICS AG
DELPHI GENETICS S.A.
FINVECTOR VISION THERAPIES OY
FUJIFILM DIOSYNTH BIOTECHNOLOGIES INC.
GENSCRIPT BIOTECH CORP.
GENEZEN LABORATORIES
GENERAL ELECTRIC CO.
IMMUSOFT CORP.
LAKEPHARMA INC.
LONZA GROUP LTD.
LYSOGENE SA
MAXCYTE INC.
MERCK KGAA
NOVARTIS INTERNATIONAL AG
NOVASEP HOLDING SAS
ORCHARD THERAPEUTICS PLC
ORIGENE TECHNOLOGIES INC.
OXFORD BIOMEDICA PLC
OXFORD GENETICS LTD.
PFIZER INC.
PLASMIDFACTORY GMBH & CO. KG
POSEIDA THERAPEUTICS INC.
PROMEGA CORP.
PSIOXUS THERAPEUTICS LTD.
REGENXBIO INC.
REPLIGEN CORP.
ROCKET PHARMACEUTICALS, LTD.
SANGAMO THERAPEUTICS INC.
SIRION-BIOTECH GMBH
SIGNAGEN LABORATORIES
SPARK THERAPEUTICS INC.
THERMO FISHER SCIENTIFIC, INC.
ULTRAGENYX PHARMACEUTICAL INC.
UNIQURE N.V.
VGXI INC.
VIGENE BIOSCIENCES INC.
WAISMAN BIOMANUFACTURING
YPOSKESI INC.

List of Tables

Summary Table : Global Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 1 : Types of Gene Therapy
Table 2 : Clinical Trials for Viral Vector-Mediated Gene Therapy in the U.S., 2018 and 2019
Table 3 : Partnerships for Viral Vector-Mediated Gene Therapy
Table 4 : Global Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 5 : Characteristics of Plasmid DNA Isolation Technology, 2019
Table 6 : Global Market for Plasmid DNA, by Region, Through 2024
Table 7 : Global Market for Viral Vector, by Region, Through 2024
Table 8 : Global Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 9 : Global Market for Viral Vector and Plasmid DNA in Research Institutes, by Region, Through 2024
Table 10 : Global Market for Viral Vector and Plasmid DNA in Pharmaceutical and Biopharmaceutical Companies, by Region, Through 2024
Table 11 : Global Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 12 : Viral Vectors Used in Gene Therapy
Table 13 : Global Market Viral Vector and Plasmid DNA in Cancer, by Region, Through 2024
Table 14 : Pipeline Products for Cancer Gene Therapy, 2018 and 2019
Table 15 : Global Market for Viral Vector and Plasmid DNA in Infectious Diseases, by Region, Through 2024
Table 16 : Gene Transfer Vectors Used in Heart Gene Therapy
Table 17 : Global Market for Viral Vector and Plasmid DNA in CVD, by Region, Through 2024
Table 18 : Global Market for Viral Vector and Plasmid DNA in Other Applications, by Region, Through 2024
Table 19 : Global Market for Viral Vector and Plasmid DNA, by Region, Through 2024
Table 20 : New Cases of Tuberculosis, by Country, 2017
Table 21 : Ebola Virus Disease Outbreaks in Chronological Order, 2012-2019
Table 22 : North American Market for Viral Vector and Plasmid DNA, by Country, Through 2024
Table 23 : North American Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 24 : North American Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 25 : North American Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 26 : Research Institutes for Gene Therapy in the U.S.
Table 27 : New Cancer Cases in the U.S., by Gender, 2019
Table 28 : New Cancer Cases Diagnosed in Canada, 2019
Table 29 : European Market for Viral Vector and Plasmid DNA, by Country, Through 2024
Table 30 : European Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 31 : European Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 32 : European Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 33 : New Cancer Cases and Mortalities in France, 2018
Table 34 : New Cancer Cases in European Countries, 2018
Table 35 : Asia-Pacific Market for Viral Vector and Plasmid DNA, by Country, Through 2024
Table 36 : Asia-Pacific Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 37 : Asia-Pacific Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 38 : Asia-Pacific Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 39 : New Cancer Cases and Mortalities in China, 2018
Table 40 : New Cancer Cases in Asia-Pacific Countries, 2018
Table 41 : MEA Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 42 : MEA Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 43 : MEA Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 44 : Latin American Market for Viral Vector and Plasmid DNA, by Product Type, Through 2024
Table 45 : Latin American Market for Viral Vector and Plasmid DNA, by Application, Through 2024
Table 46 : Latin American Market for Viral Vector and Plasmid DNA, by End User, Through 2024
Table 47 : New Product Developments, 2017-2019
Table 48 : Number of Patents Grants, by Categories in Different Countries, January 2017-July 2019
Table 49 : Number of Patents, by Key Players in the U.S., Europe and Japan, January 2017-July 2019
Table 50 : Total Number of Analyzed Patents, January 2017-July 2019
Table 51 : Key Financial Statistics of Thermo Fisher Scientific, Inc., 2017 and 2018
Table 52 : Key Financial Statistics of Merck KGaA, 2017 and 2018
Table 53 : Key Financial Statistics of Lonza Group Ltd., 2017 and 2018
Table 54 : Key Financial Statistics of GenScript Biotech Corp., 2017 and 2018
Table 55 : Key Financial Statistics of Pfizer Inc., 2017 and 2018
Table 56 : Viral Vector-Mediated Gene Therapies in Development, 2018 and 2019
Table 57 : Viral Vector-Mediated Gene Therapy Clinical Trials Database, 2018"

List of Figures

Summary Figure : Global Market for Viral Vector and Plasmid DNA, by Product Type, 2018-2024
Figure 1 : Processes of Gene Therapy Research
Figure 2 : Processes of Gene Therapy Development
Figure 3 : Typical Production Process Flow for Viral Vectors
Figure 4 : Most Common Cancer Types, Global Cases, 2018
Figure 5 : Progression of cGMP Compliance for Drug Development
Figure 6 : Shares of New Cancer Cases, Globally, by Cancer Type, 2018
Figure 7 : Shares of New Cancer Cases in North America, by Cancer Type, 2018
Figure 8 : Shares of New Cancer Cases in Europe, by Cancer Type, 2018
Figure 9 : Prevalence of Cancer in U.K., 2011-2017
Figure 10 : Prevalence of Cancer in Germany, by Cancer Type, 2014-2016
Figure 11 : Colorectal Cancer Incidences in Italy, 2015 and 2016
Figure 12 : Prevalence of Colorectal Cancer in Spain, 2011-2016
Figure 13 : Shares of New Cancer Cases in Asia, by Cancer Type, 2018
Figure 14 : Shares of New Cancer Cases in Oceania, by Cancer Type, 2018
Figure 15 : Shares of New Cancer Cases in Japan, by Cancer Type, 2018
Figure 16 : Shares of New Cancer Cases in India, by Cancer Type, 2018
Figure 17 : Pharmaceutical Expenditures per Capita, by Country, 2015
Figure 18 : Shares of New Cancer Cases in MEA, by Cancer Type, 2018
Figure 19 : New HIV Cases and Mortalities in MEA, 2017
Figure 20 : Shares of New Cancer Cases in Latin America and the Caribbean, by Cancer Type, 2018

  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs